247 related articles for article (PubMed ID: 20164475)
1. Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.
Parks M; Rosebraugh C
N Engl J Med; 2010 Mar; 362(9):774-7. PubMed ID: 20164475
[No Abstract] [Full Text] [Related]
2. Liraglutide and calcitonin.
Bloomgarden Z
J Diabetes; 2010 Dec; 2(4):223-4. PubMed ID: 21140545
[No Abstract] [Full Text] [Related]
3. An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development.
Viereck C; Boudes P
Contemp Clin Trials; 2011 May; 32(3):324-32. PubMed ID: 21266202
[TBL] [Abstract][Full Text] [Related]
4. [The new antidiabetic agents in the firing line.... safety reasons or witch hunt?].
Nicolau Ramis J; Masmiquel Comas L
Endocrinol Nutr; 2012 Jan; 59(1):1-8. PubMed ID: 22177885
[No Abstract] [Full Text] [Related]
5. Liraglutide (Victoza) for type 2 diabetes.
Med Lett Drugs Ther; 2010 Apr; 52(1335):25-7. PubMed ID: 20360660
[TBL] [Abstract][Full Text] [Related]
6. [Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].
Jahn E; Sausele T
Med Monatsschr Pharm; 2009 Nov; 32(11):402-7. PubMed ID: 19947303
[TBL] [Abstract][Full Text] [Related]
7. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
Montanya E; Sesti G
Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide: from clinical trials to clinical practice.
Gough SC
Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():33-40. PubMed ID: 22405267
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide in oral antidiabetic drug combination therapy.
Garber AJ
Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():13-9. PubMed ID: 22405265
[TBL] [Abstract][Full Text] [Related]
10. Late and severe acute necrotizing pancreatitis in a patient with liraglutide.
Bourezane H; Kastler B; Kantelip JP
Therapie; 2012; 67(6):539-43. PubMed ID: 23249582
[No Abstract] [Full Text] [Related]
11. New drugs: Liraglutide, dalfampridine, and abobotulinumtoxinA.
Hussar DA; Kaczinski J
J Am Pharm Assoc (2003); 2010; 50(3):436-9. PubMed ID: 20452924
[No Abstract] [Full Text] [Related]
12. Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage.
Moses A
BMJ; 2013 Jul; 347():f4386. PubMed ID: 23842435
[No Abstract] [Full Text] [Related]
13. Pancreatitis: a potential complication of liraglutide?
Franks AS; Lee PH; George CM
Ann Pharmacother; 2012 Nov; 46(11):1547-53. PubMed ID: 23136352
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer.
Chalmer T; Almdal TP; Vilsbøll T; Knop FK
Expert Opin Drug Saf; 2015 Jan; 14(1):171-80. PubMed ID: 25363438
[TBL] [Abstract][Full Text] [Related]
15. FDA is to assess data linking type 2 diabetes drugs with pancreatitis.
Cohen D
BMJ; 2013 Mar; 346():f1808. PubMed ID: 23512765
[No Abstract] [Full Text] [Related]
16. Liraglutide.
Drucker DJ; Dritselis A; Kirkpatrick P
Nat Rev Drug Discov; 2010 Apr; 9(4):267-8. PubMed ID: 20357801
[TBL] [Abstract][Full Text] [Related]
17. [Beta-cell function in the foreground. GLP-1 based therapy of type 2 diabetes].
Kern W
MMW Fortschr Med; 2010 Jan; 151 Suppl 4():173-8. PubMed ID: 21595145
[No Abstract] [Full Text] [Related]
18. Vesiculopustular dermatosis: an uncommon side-effect of liraglutide?
Besemer F; Verschoor AJ; Diamant M; Hoogma RP
J Diabetes Complications; 2012; 26(5):458-9. PubMed ID: 22727533
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.
Alves C; Batel-Marques F; Macedo AF
Diabetes Res Clin Pract; 2012 Nov; 98(2):271-84. PubMed ID: 23010561
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide: clinical pharmacology and considerations for therapy.
Sisson EM
Pharmacotherapy; 2011 Sep; 31(9):896-911. PubMed ID: 21923591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
